ATE389013T1 - Faktor x-analoge mit verbesserter fähigkeit zur aktivierung - Google Patents

Faktor x-analoge mit verbesserter fähigkeit zur aktivierung

Info

Publication number
ATE389013T1
ATE389013T1 AT00949465T AT00949465T ATE389013T1 AT E389013 T1 ATE389013 T1 AT E389013T1 AT 00949465 T AT00949465 T AT 00949465T AT 00949465 T AT00949465 T AT 00949465T AT E389013 T1 ATE389013 T1 AT E389013T1
Authority
AT
Austria
Prior art keywords
factor
analogue
activate
improved capability
analog
Prior art date
Application number
AT00949465T
Other languages
English (en)
Inventor
Michele Himmelspach
Uwe Schlokat
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of ATE389013T1 publication Critical patent/ATE389013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT00949465T 1999-08-10 2000-08-07 Faktor x-analoge mit verbesserter fähigkeit zur aktivierung ATE389013T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0137799A AT410216B (de) 1999-08-10 1999-08-10 Faktor x-analogon mit verbesserter aktivierbarkeit

Publications (1)

Publication Number Publication Date
ATE389013T1 true ATE389013T1 (de) 2008-03-15

Family

ID=3512576

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0137799A AT410216B (de) 1999-08-10 1999-08-10 Faktor x-analogon mit verbesserter aktivierbarkeit
AT00949465T ATE389013T1 (de) 1999-08-10 2000-08-07 Faktor x-analoge mit verbesserter fähigkeit zur aktivierung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0137799A AT410216B (de) 1999-08-10 1999-08-10 Faktor x-analogon mit verbesserter aktivierbarkeit

Country Status (9)

Country Link
US (1) US6958322B1 (de)
EP (1) EP1238065B1 (de)
AT (2) AT410216B (de)
AU (1) AU778571B2 (de)
CA (1) CA2380844A1 (de)
DE (1) DE60038312T2 (de)
DK (1) DK1238065T3 (de)
ES (1) ES2302696T3 (de)
WO (1) WO2001010896A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
BRPI0514396A2 (pt) * 2004-08-17 2009-05-12 Csl Behring Gmbh polipeptìdeos dependentes de vitamina k modificada
EP1728798A1 (de) * 2005-06-01 2006-12-06 ZLB Behring GmbH Blutgerinnungsfaktor X Polypeptide mit veränderten Aktivierungseigenschaften
MX336958B (es) * 2005-11-15 2016-02-05 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
EP1820508A1 (de) * 2006-02-21 2007-08-22 CSL Behring GmbH Polypeptide des Gerinnfaktors X mit geänderten Aktivierungseigenschaften
PT2157177E (pt) * 2007-05-22 2013-04-18 Baxter Int Processo de purificação preparativo para a furina humana
TWI492951B (zh) 2007-12-31 2015-07-21 Baxter Int 表現人類凝血因子的基因轉殖非人類動物及其用途
WO2011017414A2 (en) 2009-08-04 2011-02-10 Baxter International Inc. Transgenic mouse lacking endogenous fviii and vwf - a model of hemophilia a
US9371522B2 (en) 2011-09-30 2016-06-21 The Children's Hospital Of Philadelphia Compositions and methods for modulating hemostasis
SG11201500579SA (en) 2012-07-25 2015-02-27 Catalyst Biosciences Inc Modified factor x polypeptides and uses thereof
KR20150103205A (ko) 2013-01-31 2015-09-09 화이자 인코포레이티드 인자 Xa 억제를 길항하기 위한 조성물 및 방법
FR3001729B1 (fr) * 2013-02-04 2015-03-06 Lab Francais Du Fractionnement Mutants du facteur x
SG11201601221XA (en) 2013-09-24 2016-04-28 Pfizer Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
US10676731B2 (en) 2014-08-19 2020-06-09 The Children's Hospital Of Philadelphia Compositions and methods for modulating factor IX function
FR3050992A1 (fr) * 2016-05-06 2017-11-10 Lab Francais Du Fractionnement Mutants du facteur x

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT366916B (de) 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
US4501731A (en) 1983-06-27 1985-02-26 Tishkoff Garson H Treatment of disparate bleeding disorders with factor X zymogen
AT382783B (de) 1985-06-20 1987-04-10 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
US5597799A (en) 1990-09-04 1997-01-28 Cor Therapeutics, Inc. Recombinant agents affecting thrombosis
EP0785273A1 (de) 1990-11-26 1997-07-23 Genetics Institute, Inc. Gepaarte basische Aminosäuren konvertierendes Enzym und dafür kodierende DNA Sequenz
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
DE4325872C1 (de) 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
AT404838B (de) 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
AT405517B (de) 1997-02-27 1999-09-27 Immuno Ag Faktor x-deletionsmutanten und analoge davon
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle

Also Published As

Publication number Publication date
US6958322B1 (en) 2005-10-25
AU6280700A (en) 2001-03-05
AT410216B (de) 2003-03-25
CA2380844A1 (en) 2001-02-15
DK1238065T3 (da) 2008-07-07
WO2001010896A3 (en) 2002-07-11
ES2302696T3 (es) 2008-08-01
EP1238065A2 (de) 2002-09-11
WO2001010896A2 (en) 2001-02-15
ATA137799A (de) 2002-07-15
AU778571B2 (en) 2004-12-09
EP1238065B1 (de) 2008-03-12
DE60038312T2 (de) 2009-03-26
DE60038312D1 (de) 2008-04-24

Similar Documents

Publication Publication Date Title
DE60038312D1 (de) Faktor x-analoge mit verbesserter fähigkeit zur aktivierung
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
DE69908998D1 (de) Verfahren zur Herstellung von Kohlenstoff
DE60006298D1 (de) Verfahren zur Herstellung von Kohlendioxid
ATE310009T1 (de) Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
DE69909003D1 (de) Verfahren zur Herstellung von Polyamiden
DE69424806D1 (de) Vorrichtung zur Herstellung von Stempeln
DE69624268D1 (de) Anlage zur herstellung von polstermaterial
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE60201498D1 (de) Verbesserter prozess zur herstellung von carbapenemen
DE50015943D1 (de) Verfahren zur Herstellung von Düngemittelpressgranulaten
DE60008830D1 (de) Verfahren zur Herstellung von keramischen Zusammensetzungen
DE60100217D1 (de) Verfahren zur Herstellung von hochkonzentrierten Kohlendioxid
DE50213015D1 (de) Lipase-varianten
DE60002254D1 (de) Verfahren zur Herstellung von 4,6-diaminoresorcin
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen
DE69916332D1 (de) Verfahren zur herstellung von etheraminalkoxylaten
DE69812438T2 (de) Zusammensetzung zur herstellung von brennstoff-briketts
DE50010478D1 (de) Verfahren zur herstellung von polyamiden
DE19983485T1 (de) Verfahren zur Herstellung von Gasfedern
ATE267820T1 (de) Prozess zur herstellung von paclitaxel
ATE290096T1 (de) Coenzym zur herstellung von l-carnitin
DE50000038D1 (de) Verfahren zur Herstellung von Organochlorsilanen
DE10082578D2 (de) Verfahren zur Herstellung von regelmäßigen Nanostrukturen
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1238065

Country of ref document: EP